• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:GNVR)

0.5500 +0.0300 (+5.77%)
Streaming Delayed Price Updated: 9:41 AM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,000
Open 0.5200
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.5200
Today's Range 0.5200 - 0.5500
52wk Range 0.0140 - 2.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline
April 14, 2026
Establishes framework targeting multi-product commercialization across high-growth health and wellness categories with scalable revenue potential 
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026
March 05, 2026
Via ACCESS Newswire

Performance

YTD
-57.7%
-57.7%
1 Month
-30.6%
-30.6%
3 Month
-26.7%
-26.7%
6 Month
-71.1%
-71.1%
1 Year
-45.0%
-45.0%

More News

Read More
News headline image
Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions
March 04, 2026
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
February 11, 2026
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco
February 27, 2024
Via ACCESSWIRE
News headline image
Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization
January 28, 2026
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
January 20, 2026
From Genvor Inc
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
December 09, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Genvor to Attend BioSolutions Conference & Expo in Visalia, California
February 20, 2024
Via ACCESSWIRE
News headline image
Genvor to Present at the Life Sciences Virtual Investor Forum December 11th
December 04, 2025
From Virtual Investor Conferences; Genvor, Inc.
Via GlobeNewswire
News headline image
Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies
December 02, 2025
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor Inc. Partners With B2i Digital as Featured Company to Expand Investor Awareness
November 26, 2025
Via NewMediaWire
Topics Intellectual Property
News headline image
Genvor Provides Fiscal First Quarter 2024 Corporate Update
February 15, 2024
Via ACCESSWIRE
News headline image
Genvor Appoints Veteran Agribusiness Leader Chad Pawlak as Chief Executive Officer
January 17, 2024
Via ACCESSWIRE
News headline image
Genvor Inc. Partners With B2i Digital as Featured Company to Expand Investor Awareness
November 26, 2025
Via TheNewswire.com
Topics Intellectual Property
News headline image
Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide
November 12, 2025
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor Restores Trading Status and Expands Global Collaborative Research Network
October 09, 2025
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor to Unveil Latest Research on Patented Peptides for Aflatoxin Resistance in Corn at BioAgTech World Congress
April 22, 2024
Via ACCESSWIRE
News headline image
Genvor to Participate in BioAgTech World Congress in Raleigh, North Carolina
April 02, 2024
Via ACCESSWIRE

Frequently Asked Questions

Is GNVR publicly traded?
Yes, GNVR is publicly traded.
What exchange does GNVR trade on?
GNVR trades on the OTC Traded
What is the ticker symbol for GNVR?
The ticker symbol for GNVR is GNVR on the OTC Traded
What is the current price of GNVR?
The current price of GNVR is 0.5500
When was GNVR last traded?
The last trade of GNVR was at 04/24/26 09:41 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap